Chayce David Clark
Known title: EVP and General CounselCIK: 0001873048
Associated companies
Transaction History
| NUS | ▲ Buy | Grant | 138,971 | $0 | 3/6/2026 | View on chart |
| NUS | ▼ Sell | Tax Withholding | 45,502 | $393K | 2/26/2026 | View on chart |
| NUS | ▼ Sell | Tax Withholding | 17,947 | $150K | 2/15/2026 | View on chart |
| NUS | ▲ Buy | Grant | 15,667 | $0 | 2/10/2026 | View on chart |
| NUS | ▲ Buy | Grant | 75,466 | $0 | 2/10/2026 | View on chart |
| NUS | ▼ Sell | Tax Withholding | 9,049 | $93K | 12/20/2025 | View on chart |
| NUS | ▼ Sell | Open Market | 20,000 | $239K | 9/3/2025 | View on chart |
| NUS | ▼ Sell | Tax Withholding | 205 | $2K | 8/1/2025 | View on chart |
| NUS | ▲ Buy | Grant | 113,196 | $0 | 2/26/2025 | View on chart |
| NUS | ▼ Sell | Tax Withholding | 14,227 | $108K | 2/15/2025 | View on chart |
| NUS | ▲ Buy | Grant | 6,451 | $0 | 2/12/2025 | View on chart |
| NUS | ▼ Sell | Tax Withholding | 9,070 | $60K | 12/20/2024 | View on chart |
| NUS | ▼ Sell | Tax Withholding | 206 | $2K | 8/1/2024 | View on chart |
| NUS | ▼ Sell | Tax Withholding | 974 | $13K | 6/5/2024 | View on chart |
| NUS | ▲ Buy | Grant | 69,116 | $0 | 2/27/2024 | View on chart |
| NUS | ▼ Sell | Tax Withholding | 5,586 | $77K | 2/15/2024 | View on chart |
| NUS | ▲ Buy | Grant | 3,522 | $0 | 2/13/2024 | View on chart |
| NUS | ▼ Sell | Tax Withholding | 9,070 | $175K | 12/20/2023 | View on chart |
| NUS | ▼ Sell | Tax Withholding | 206 | $6K | 8/1/2023 | View on chart |
| NUS | ▼ Sell | Tax Withholding | 979 | $33K | 6/5/2023 | View on chart |
| NUS | ▲ Buy | Grant | 18,090 | $0 | 2/22/2023 | View on chart |
| NUS | ▼ Sell | Tax Withholding | 1,303 | $59K | 2/15/2023 | View on chart |
| NUS | ▲ Buy | Grant | 61,836 | $0 | 12/20/2022 | View on chart |
| NUS | ▼ Sell | Tax Withholding | 137 | $6K | 8/1/2022 | View on chart |
| NUS | ▼ Sell | Tax Withholding | 649 | $30K | 6/5/2022 | View on chart |
| NUS | ▲ Buy | Grant | 8,430 | $0 | 2/25/2022 | View on chart |
| NUS | ▼ Sell | Tax Withholding | 865 | $43K | 2/15/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Nu Skin: Turnaround Narrative Gains Attention
A recent analysis suggests that Nu Skin's potential turnaround may be in its early stages. The company currently trades at a low price with a high dividend yield, while the stock is testing a key support level. This context highlights the contrast between current market sentiment and the long-term outlook discussed in the news.
Nu Skin: Turnaround Narrative Gains Attention. A recent analysis suggests that Nu Skin's potential turnaround may be in its early stages. The company currently trades at a low price with a high dividend yield, while the stock is testing a key support level. This context highlights the contrast between current market sentiment and the long-term outlook discussed in the news.